Public Employees Retirement Association of Colorado cut its stake in Clorox Co (NYSE:CLX) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,217 shares of the company’s stock after selling 1,088 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Clorox were worth $3,411,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the business. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Clorox by 67.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 172 shares of the company’s stock valued at $26,000 after buying an additional 69 shares in the last quarter. Savior LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $31,000. Strategic Blueprint LLC acquired a new stake in shares of Clorox in the third quarter valued at approximately $37,000. Usca Ria LLC acquired a new stake in shares of Clorox in the third quarter valued at approximately $41,000. Finally, Wealthcare Advisory Partners LLC increased its holdings in shares of Clorox by 48.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 307 shares of the company’s stock valued at $47,000 after purchasing an additional 100 shares in the last quarter. 78.06% of the stock is owned by institutional investors.
In other Clorox news, SVP Diego J. Barral sold 2,086 shares of the stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $165.62, for a total transaction of $345,483.32. Following the transaction, the senior vice president now owns 8,247 shares in the company, valued at approximately $1,365,868.14. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Denise Garner sold 725 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $146.34, for a total transaction of $106,096.50. Following the transaction, the senior vice president now owns 5,805 shares in the company, valued at approximately $849,503.70. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.31 by $0.15. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Clorox had a net margin of 13.31% and a return on equity of 133.50%. The firm’s revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.40 EPS. Sell-side analysts forecast that Clorox Co will post 6.19 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be given a dividend of $1.06 per share. The ex-dividend date of this dividend is Tuesday, April 21st. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.58%. Clorox’s payout ratio is presently 67.09%.
CLX has been the subject of a number of research reports. Credit Suisse Group reissued a “buy” rating and issued a $168.00 price target on shares of Clorox in a report on Sunday, February 2nd. Cfra reissued a “sell” rating and issued a $140.00 price target (up previously from $130.00) on shares of Clorox in a report on Tuesday, February 4th. Deutsche Bank raised their price target on shares of Clorox from $147.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, February 5th. Morgan Stanley raised their price target on shares of Clorox from $134.00 to $144.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Finally, Barclays reissued a “sell” rating on shares of Clorox in a report on Thursday, February 6th. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $152.23.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: How is the discount rate different from the Federal Funds rate?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.